Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)
This grant opportunity offers funding for research to test the effectiveness of treatments in rare disease models. It supports studies on how treatments work in the body and how they are processed. Eligible treatments include small molecules and biotech products. The aim is to advance projects to attract further investment for full drug development or clinical trials, particularly for repurpos…
This notice of funding opportunity (NOFO) provides funding to conduct efficacy studies in an established rare disease preclinical model to demonstrate that a proposed therapeutic agent warrants further development. In addition to preclinical efficacy, accompanying pharmacodynamic and pharmacokin…
Funding Source
Awards & funding
Dates
Supporting links
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers